[Acute generalized exanthematous pustulosis included by hydroxychloroquine during lupus].
Fain
Olivier
O
Service de médecine interne, Hôpital Jean-Verdier (AP-HP), Université Paris-13, 93140 Bondy. olivier.fain@jvr.aphp.fr
Stirnemann
Jérôme
J
Kettaneh
Adrien
A
D018501:Antirheumatic Agents / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology; D005076:Exanthema / Q000139:chemically induced*; D005260:Female; D006801:Humans; D006886:Hydroxychloroquine / Q000009:adverse effects*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy*; D017444:Skin Diseases, Papulosquamous / Q000139:chemically induced*; D055815:Young Adult
D018501:Antirheumatic Agents; D006886:Hydroxychloroquine